MARKET DEFINITION

Antidotes are substances that counteract the effects of a poison or toxin. Antidotes work by either stopping toxin absorption, binding and neutralising the poison, antagonising its end-organ impact, or inhibiting toxin conversion to more harmful metabolites. Antidote treatment results not only in a decrease in free or active toxin levels, but also in a reduction in the toxin's end-organ effects via mechanisms such as competitive inhibition, receptor blocking, or direct antagonism of the toxin. Toxin antidotes are created by injecting the toxin into an animal in modest dosages and collecting the resultant antibodies from the host animals' blood.

MARKET DYNAMICS

The global antidotes market is anticipated to be driven by growing awareness and research on the identification of toxins in venomous bites to better understand antidotes and medications. Additionally, demand for antidotes is driven by an increase in the occurrence of medical problems connected with antidotes, such as reversal of sedation, prohylaxis, and opioid overdose. However, the antidote market has a few constraints, such as poor anti-venom production due to increased anti-venom pricing, which has stifled demand, causing treatment to fall drastically or even disappear in some places, which is projected to stifle the antidote market's growth. Furthermore, rising concern regarding the efficacy of antidotes has resulted in the exchange of information, and clinical experience among health care professionals and scientists across the globe, which is expected to offer lucrative opportunities for the market.

REPORT SCOPE  

The report titled “Global Antidotes Market – Size, Share, Growth, Opportunities, and Competitive Analysis, 2022 – 2028” offers strategic visions into the global Antidotes market along with the market size (Value in “US$ Mn”) for the historical period 2017 to 2021 and estimates for the forecast period 2022 to 2028. The RI report is an in-depth study of the global Antidotes market with a strong focus on key market trends, vital player strategies, and market forecasts. The study also covers key market dynamics, including drivers, restraints, opportunities, challenges, and existing and upcoming pathways that help CXOs make critical business decisions effectively. The global Antidotes Market is predicted to grow at a significant CAGR over the forecast period from 2022 to 2028.

GEOGRAPHICAL OVERVIEW

The research report includes a detailed overview of the industry comprising quantitative and qualitative information. It gives a broad overview of the worldwide market forecasts for major segments. It also includes market size and forecast projections for five key regions: North America, Europe, Asia-Pacific (APAC), South America, and the Middle East & Africa (MEA), for the years 2017 to 2028. The market is further divided by categories and countries within each province. The research scrutinizes and forecasts over 20 nations worldwide, as well as the present trend and possibilities in these regions.

MARKET SEGMENTATION

The Global Antidotes Market is segmented based on type, application, route of administration, sales channel, and region. Based on type, the market has been segmented into Physiological Antidote, Chemical Antidote, and Mechanical Antidote, whereas based on application, the market comprises Poison, Drug, and Toxin. Based on route of Administrations, the market has been segmented into Injection, and Oral, whereas, the Sales Channel segmentation includes Hospital, Pharmaceutical Companies, and Others.

COMPETITION LANDSCAPE

The RI research report discusses noteworthy developments in the industry as well as organic and inorganic growth strategies being adopted by the Antidotes market players. The report covers industry activities, including new product launches, mergers & acquisitions, business partnerships, and various expansion initiatives being undertaken by the active players in the market. These developments pave the path for various market participants to strengthen their positioning as well as expand their consumer base. The positive market outlook for the global Antidotes market is anticipated to present lucrative growth opportunities to the market players. The report also offers detailed profiles of major players in the global Antidotes market, emphasizing the strategic initiatives, financial information, SWOT analysis, and key development in the Antidotes industry in the past three years.

Key players in the Global Antidotes Market have adopted various organic as well as inorganic growth strategies to strengthen their market positioning. Prominent players in the market include:

• ADAPT Pharma, Inc.
• Baxter International, Inc.
• Cumberland Pharmaceuticals, Inc.
• Meridian Medical Technologies, Inc.
• Graceway Pharmaceuticals, LLC
• Luitpold Pharmaceuticals, Inc.
• Novartis AG
• Protherics, Inc.
• ApoPharma USA, Inc.
• Apotex, Inc.
• Spectrum Pharmaceuticals, Inc.

COVID-19 IMPACT ANALYSIS ON GLOBAL ANTIDOTES MARKET

The COVID-19 pandemic is still a very personal, individual experience that is also a once-in-a-lifetime worldwide phenomenon with far-reaching consequences. The epidemic has wreaked havoc on people's lives in all nations and communities and also had a negative impact on global economic development in 2020, unlike anything seen in almost a century. The pandemic severely impacted key economies such as India, Brazil, the U.S., France, Russia, the UK, Italy, Turkey, and Argentina. According to estimates, the virus slowed global economic growth by -3.4 percent to -7.6 percent in 2020, with a rebound of 4.2 percent to 5.6 percent expected in 2021. In 2020, global commerce was expected to decline by 5.3 percent, but it is expected to rise by 8.0 percent in 2021.

In contrast to the global economic downturn in the first half of 2020, the economy began to showcase symptoms of a two-track recovery post the second quarter of 2020, with a fledgling rebound in developed nations, however, slower growth in emerging economies. The outbreak of the Covid-19 pandemic has not only resulted in halted production activity but has also disrupted the global supply chain. The research goes on to evaluate the current and future implications of the COVID-19 pandemic both on the target as well as broader market, thereby, providing accurate and trustworthy forecasts.

RESEARCH PROGRAM DESIGN

KEY QUESTIONS ANSWERED

1. What is the current size of the global Antidotes market?
2. What will be the growth rate of the market over the forecast period?
3. Who are the key manufacturers/vendors in the Antidotes market space?
4. What are the major market opportunities and market risks faced by the market?
5. What is the impact of COVID-19 on the market?
6. What are the revenue, sales, and price analysis of the top manufacturers in this market?
7. What are the key outcomes of Porter's five forces model?
8. Who are the distributors, traders, and vendors in the industry?

REASONS FOR BUYING THIS REPORT:

• The report offers comprehensive data on the Antidotes market elaborating on the current state and future growth prospects both globally and regionally
• It offers a six-year market forecast trend evaluating the impact of drivers and restraints and supporting factors for growth
• The report offers deep-dive insights into each market segment and critical factors responsible for its growth
• The report presents precise picture of the dynamic competitive landscape which helps our client advance their market position
• The comprehensive analysis of the market along with the inclusion of analyst recommendations ensures that our clients make informed business decisions
• Cross-segment country-level analysis included in the report which provides granular analysis of more than 20+ countries covered in the report scope
• The study includes detailed profiles of major manufacturers to help our readers gain holistic overview of the market competitors and consequently align their business strategies

Chapter 1. Executive Summary
1.1. Market Outlook
1.2. Market Segment Outlook
1.3. Geography Outlook
1.4. Absolute $ Opportunity
 
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Scope, Definition, and Assumptions
2.3. Data Sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary Data Mining
2.3.2. Primary Sources
2.3.2.1. Statistical Route of Administrations
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
 
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key Trends
3.2.1. Type Trends
3.2.2. Application Trends
3.2.3. Route of Administrations Trends
3.2.4. Sales Channel Trends
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Impact Analysis of Market Drivers
3.3.2. Market Restraints
3.3.2.1. Impact Analysis of Market Restraints
3.3.3. Market Opportunities
3.3.3.1. Impact Analysis of Market Opportunities
3.3.4. Market Challenges
3.3.4.1. Impact Analysis of Market Challenges
3.4. Porter’s Five Forces’ Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of New Entrant
3.4.4. Threat of Substitutes
3.4.5. Competitive Rivalry
3.5. Value Chain Analysis: Global Antidotes Market
3.6. COVID-19 Impact Assessment in Antidotes Market
3.6.1. Impact Assessment on Global Antidotes Market
3.6.2. Market Trends and Opportunities in the Covid-19 Landscape
 
Chapter 4. Global Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
4.1. Global Antidotes Market Share, By Type, 2017 - 2028 (USD Million)
4.1.1. Physiological Antidote
4.1.2. Chemical Antidote
4.1.3. Mechanical Antidote
 
Chapter 5. Global Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
5.1. Global Antidotes Market Share, By Application, 2017 - 2028 (USD Million)
5.1.1. Poison
5.1.2. Drug
5.1.3. Toxin
 
Chapter 6. Global Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
6.1. Global Antidotes Market Share, By Route of Administrations, 2017 - 2028 (USD Million)
6.1.1. Injection
6.1.2. Oral
 
Chapter 7. Global Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
7.1. Global Antidotes Market Share, By Sales Channel, 2017 - 2028 (USD Million)
7.1.1. Hospital
7.1.2. Pharmaceutical Companies
7.1.3. Others
 
Chapter 8. Global Antidotes Market Overview, By Geography, 2017 - 2028 (USD Million)
8.1. Global Antidotes Market Share, By Geography, 2017 - 2028 (USD Million)
8.1.1. Market Deployment and Projections, by Countries, 2017 - 2028 (USD Million)
8.1.2. Market Share and CAGR Comparison, by Countries, 2021 (%)
 
Chapter 9. North America Antidotes Market Overview, By Countries, 2017 - 2028 (USD Million)
9.1. North America Antidotes Market Overview, 2017 - 2028 (USD Million)
9.1.1. Market Deployment and Projections, 2017 - 2028 (USD Million)
9.1.2. North America Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
9.1.3. North America Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
9.1.4. North America Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
9.1.5. North America Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
9.2. North America Antidotes Market Overview, By Countries, 2017 - 2028 (USD Million)
9.2.1. U.S. Antidotes Market Overview, 2017 - 2028 (USD Million)
9.2.1.1. U.S. Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
9.2.1.2. U.S. Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
9.2.1.3. U.S. Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
9.2.1.4. U.S. Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
9.2.2. Canada Antidotes Market Overview, 2017 - 2028 (USD Million)
9.2.2.1. Canada Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
9.2.2.2. Canada Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
9.2.2.3. Canada Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
9.2.2.4. Canada Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
9.2.3. Mexico Antidotes Market Overview, 2017 - 2028 (USD Million)
9.2.3.1. Mexico Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
9.2.3.2. Mexico Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
9.2.3.3. Mexico Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
9.2.3.4. Mexico Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
 
Chapter 10. Europe Antidotes Market Overview, By Countries, 2017 - 2028 (USD Million)
10.1. Europe Antidotes Market Overview, 2017 - 2028 (USD Million)
10.1.1. Market Deployment and Projections, 2017 - 2028 (USD Million)
10.1.2. Europe Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
10.1.3. Europe Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
10.1.4. Europe Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
10.1.5. Europe Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
10.2. Europe Antidotes Market Overview, By Countries, 2017 - 2028 (USD Million)
10.2.1. Germany Antidotes Market Overview, 2017 - 2028 (USD Million)
10.2.1.1. Germany Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
10.2.1.2. Germany Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.1.3. Germany Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
10.2.1.4. Germany Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
10.2.2. France Antidotes Market Overview, 2017 - 2028 (USD Million)
10.2.2.1. France Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
10.2.2.2. France Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.2.3. France Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
10.2.2.4. France Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
10.2.3. UK Antidotes Market Overview, 2017 - 2028 (USD Million)
10.2.3.1. UK Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
10.2.3.2. UK Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.3.3. UK Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
10.2.3.4. UK Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
10.2.4. Italy Antidotes Market Overview, 2017 - 2028 (USD Million)
10.2.4.1. Italy Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
10.2.4.2. Italy Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.4.3. Italy Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
10.2.4.4. Italy Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
10.2.5. Spain Antidotes Market Overview, 2017 - 2028 (USD Million)
10.2.5.1. Spain Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
10.2.5.2. Spain Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.5.3. Spain Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
10.2.5.4. Spain Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
10.2.6. NORDIC Antidotes Market Overview, 2017 - 2028 (USD Million)
10.2.6.1. NORDIC Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
10.2.6.2. NORDIC Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.6.3. NORDIC Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
10.2.6.4. NORDIC Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
10.2.7. Russia and CIS Antidotes Market Overview, 2017 - 2028 (USD Million)
10.2.7.1. Russia and CIS Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
10.2.7.2. Russia and CIS Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.7.3. Russia and CIS Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
10.2.7.4. Russia and CIS Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
10.2.8. Rest of Europe Antidotes Market Overview, 2017 - 2028 (USD Million)
10.2.8.1. Rest of Europe Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
10.2.8.2. Rest of Europe Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.8.3. Rest of Europe Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
10.2.8.4. Rest of Europe Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
 
Chapter 11. Asia Pacific Antidotes Market Overview, By Countries, 2017 - 2028 (USD Million)
11.1. Asia Pacific Antidotes Market Overview, 2017 - 2028 (USD Million)
11.1.1. Market Deployment and Projections, 2017 - 2028 (USD Million)
11.1.2. Asia Pacific Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
11.1.3. Asia Pacific Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
11.1.4. Asia Pacific Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
11.1.5. Asia Pacific Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
11.2. Asia Pacific Antidotes Market Overview, By Countries, 2017 - 2028 (USD Million)
11.2.1. India Antidotes Market Overview, 2017 - 2028 (USD Million)
11.2.1.1. India Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
11.2.1.2. India Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
11.2.1.3. India Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
11.2.1.4. India Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
11.2.2. China Antidotes Market Overview, 2017 - 2028 (USD Million)
11.2.2.1. China Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
11.2.2.2. China Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
11.2.2.3. China Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
11.2.2.4. China Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
11.2.3. Japan Antidotes Market Overview, 2017 - 2028 (USD Million)
11.2.3.1. Japan Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
11.2.3.2. Japan Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
11.2.3.3. Japan Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
11.2.3.4. Japan Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
11.2.4. ASEAN Antidotes Market Overview, 2017 - 2028 (USD Million)
11.2.4.1. ASEAN Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
11.2.4.2. ASEAN Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
11.2.4.3. ASEAN Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
11.2.4.4. ASEAN Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
11.2.5. South Korea Antidotes Market Overview, 2017 - 2028 (USD Million)
11.2.5.1. South Korea Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
11.2.5.2. South Korea Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
11.2.5.3. South Korea Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
11.2.5.4. South Korea Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
11.2.6. Australia Antidotes Market Overview, 2017 - 2028 (USD Million)
11.2.6.1. Australia Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
11.2.6.2. Australia Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
11.2.6.3. Australia Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
11.2.6.4. Australia Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
11.2.7. Rest of Asia Pacific Antidotes Market Overview, 2017 - 2028 (USD Million)
11.2.7.1. Rest of Asia Pacific Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
11.2.7.2. Rest of Asia Pacific Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
11.2.7.3. Rest of Asia Pacific Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
11.2.7.4. Rest of Asia Pacific Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
 
Chapter 12. South America Antidotes Market Overview, By Countries, 2017 - 2028 (USD Million)
12.1. South America Antidotes Market Overview, 2017 - 2028 (USD Million)
12.1.1. Market Deployment and Projections, 2017 - 2028 (USD Million)
12.1.2. South America Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
12.1.3. South America Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
12.1.4. South America Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
12.1.5. South America Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
12.2. South America Antidotes Market Overview, By Countries, 2017 - 2028 (USD Million)
12.2.1. Brazil Antidotes Market Overview, 2017 - 2028 (USD Million)
12.2.1.1. Brazil Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
12.2.1.2. Brazil Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
12.2.1.3. Brazil Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
12.2.1.4. Brazil Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
12.2.2. Argentina Antidotes Market Overview, 2017 - 2028 (USD Million)
12.2.2.1. Argentina Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
12.2.2.2. Argentina Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
12.2.2.3. Argentina Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
12.2.2.4. Argentina Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
12.2.3. Rest of South America Antidotes Market Overview, 2017 - 2028 (USD Million)
12.2.3.1. Rest of South America Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
12.2.3.2. Rest of South America Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
12.2.3.3. Rest of South America Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
12.2.3.4. Rest of South America Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
 
Chapter 13. Middle East & Africa Antidotes Market Overview, By Countries, 2017 - 2028 (USD Million)
13.1. Middle East & Africa Antidotes Market Overview, 2017 - 2028 (USD Million)
13.1.1. Market Deployment and Projections, 2017 - 2028 (USD Million)
13.1.2. Middle East & Africa Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
13.1.3. Middle East & Africa Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
13.1.4. Middle East & Africa Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
13.1.5. Middle East & Africa Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
13.2. Middle East & Africa Antidotes Market Overview, By Countries, 2017 - 2028 (USD Million)
13.2.1. GCC Antidotes Market Overview, 2017 - 2028 (USD Million)
13.2.1.1. GCC Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
13.2.1.2. GCC Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
13.2.1.3. GCC Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
13.2.1.4. GCC Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
13.2.2. South Africa Antidotes Market Overview, 2017 - 2028 (USD Million)
13.2.2.1. South Africa Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
13.2.2.2. South Africa Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
13.2.2.3. South Africa Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
13.2.2.4. South Africa Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
13.2.3. Rest of Middle East & Africa Antidotes Market Overview, 2017 - 2028 (USD Million)
13.2.3.1. Rest of Middle East & Africa Antidotes Market Overview, By Type, 2017 - 2028 (USD Million)
13.2.3.2. Rest of Middle East & Africa Antidotes Market Overview, By Application, 2017 - 2028 (USD Million)
13.2.3.3. Rest of Middle East & Africa Antidotes Market Overview, By Route of Administrations, 2017 - 2028 (USD Million)
13.2.3.4. Rest of Middle East & Africa Antidotes Market Overview, By Sales Channel, 2017 - 2028 (USD Million)
 
Chapter 14. Competitive Landscape
14.1. Competitive Environment, 2021
14.2. Strategic Framework
14.2.1. Partnership/Collaborations/Agreement
14.2.2. Expansion
14.2.3. Mergers & Acquisitions
14.2.4. New Product Development
 
Chapter 15. Key Vendor Analysis
15.1. ADAPT Pharma, Inc.
15.1.1. Business Overview
15.1.2. Product Benchmarking
15.1.3. Financial Data
15.1.4. Strategic Overview
15.1.5. Key Developments
15.1.6. SWOT Analysis
15.2. Baxter International, Inc.
15.2.1. Business Overview
15.2.2. Product Benchmarking
15.2.3. Financial Data
15.2.4. Strategic Overview
15.2.5. Key Developments
15.2.6. SWOT Analysis
15.3. Cumberland Pharmaceuticals, Inc.
15.3.1. Business Overview
15.3.2. Product Benchmarking
15.3.3. Financial Data
15.3.4. Strategic Overview
15.3.5. Key Developments
15.3.6. SWOT Analysis
15.4. Meridian Medical Technologies, Inc.
15.4.1. Business Overview
15.4.2. Product Benchmarking
15.4.3. Financial Data
15.4.4. Strategic Overview
15.4.5. Key Developments
15.4.6. SWOT Analysis
15.5. Graceway Pharmaceuticals, LLC
15.5.1. Business Overview
15.5.2. Product Benchmarking
15.5.3. Financial Data
15.5.4. Strategic Overview
15.5.5. Key Developments
15.5.6. SWOT Analysis
15.6. Luitpold Pharmaceuticals, Inc.
15.6.1. Business Overview
15.6.2. Product Benchmarking
15.6.3. Financial Data
15.6.4. Strategic Overview
15.6.5. Key Developments
15.6.6. SWOT Analysis
15.7. Novartis AG
15.7.1. Business Overview
15.7.2. Product Benchmarking
15.7.3. Financial Data
15.7.4. Strategic Overview
15.7.5. Key Developments
15.7.6. SWOT Analysis
15.8. Protherics, Inc.
15.8.1. Business Overview
15.8.2. Product Benchmarking
15.8.3. Financial Data
15.8.4. Strategic Overview
15.8.5. Key Developments
15.8.6. SWOT Analysis
15.9. ApoPharma USA, Inc.
15.9.1. Business Overview
15.9.2. Product Benchmarking
15.9.3. Financial Data
15.9.4. Strategic Overview
15.9.5. Key Developments
15.9.6. SWOT Analysis
15.10. Apotex, Inc.
15.10.1. Business Overview
15.10.2. Product Benchmarking
15.10.3. Financial Data
15.10.4. Strategic Overview
15.10.5. Key Developments
15.10.6. SWOT Analysis
15.11. Spectrum Pharmaceuticals, Inc.
15.11.1. Business Overview
15.11.2. Product Benchmarking
15.11.3. Financial Data
15.11.4. Strategic Overview
15.11.5. Key Developments
15.11.6. SWOT Analysis
 
Chapter 16. Future Outlook of the Market